TOBAM’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1K Hold
2
﹤0.01% 250
2025
Q1
$1K Sell
2
-595
-100% -$298K ﹤0.01% 249
2024
Q4
$425K Sell
597
-347
-37% -$247K 0.13% 110
2024
Q3
$992K Sell
944
-114
-11% -$120K 0.18% 93
2024
Q2
$1.11M Sell
1,058
-2,517
-70% -$2.65M 0.17% 86
2024
Q1
$3.44M Sell
3,575
-989
-22% -$952K 0.31% 63
2023
Q4
$4.01M Sell
4,564
-730
-14% -$641K 0.35% 53
2023
Q3
$4.36M Sell
5,294
-2,274
-30% -$1.87M 0.35% 56
2023
Q2
$5.44M Sell
7,568
-7,161
-49% -$5.15M 0.41% 59
2023
Q1
$12.1M Sell
14,729
-5,577
-27% -$4.58M 0.8% 43
2022
Q4
$14.7M Buy
20,306
+6,251
+44% +$4.51M 0.97% 39
2022
Q3
$9.68M Sell
14,055
-3,959
-22% -$2.73M 0.68% 49
2022
Q2
$10.6M Sell
18,014
-18,663
-51% -$11M 0.67% 50
2022
Q1
$25.6M Buy
36,677
+1,481
+4% +$1.03M 1.29% 27
2021
Q4
$22.2M Sell
35,196
-9,721
-22% -$6.14M 1% 39
2021
Q3
$27.2M Buy
44,917
+2,499
+6% +$1.51M 1.15% 39
2021
Q2
$23.7M Sell
42,418
-1,174
-3% -$656K 0.95% 43
2021
Q1
$20.6M Buy
43,592
+249
+0.6% +$118K 0.88% 47
2020
Q4
$20.9M Buy
43,343
+3,001
+7% +$1.45M 0.93% 39
2020
Q3
$22.6M Buy
40,342
+14,174
+54% +$7.93M 1.13% 35
2020
Q2
$16.3M Buy
26,168
+24,054
+1,138% +$15M 1.05% 38
2020
Q1
$1.03M Buy
+2,114
New +$1.03M 0.08% 99
2018
Q4
Sell
-47,719
Closed -$19.3M 166
2018
Q3
$19.3M Buy
47,719
+7,716
+19% +$3.12M 0.82% 43
2018
Q2
$13.8M Buy
40,003
+5,816
+17% +$2.01M 0.57% 57
2018
Q1
$11.8M Buy
34,187
+29,095
+571% +$10M 0.48% 69
2017
Q4
$1.91M Buy
+5,092
New +$1.91M 0.08% 118
2015
Q3
Sell
-4,760
Closed -$2.43M 146
2015
Q2
$2.43M Sell
4,760
-45
-0.9% -$23K 0.09% 112
2015
Q1
$2.17M Buy
+4,805
New +$2.17M 0.07% 111